BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35193379)

  • 1. Role of adjuvant chemotherapy after concurrent chemoradiotherapy in patients with locally advanced cervical cancer.
    Kou L; Zhang T; Yang X; Peng S; Wang Y; Yuan M; Li M
    Future Oncol; 2022 May; 18(16):1917-1915. PubMed ID: 35193379
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer.
    Tangjitgamol S; Katanyoo K; Laopaiboon M; Lumbiganon P; Manusirivithaya S; Supawattanabodee B
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010401. PubMed ID: 25470408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multi-Institutional Retrospective Analysis of Oncologic Outcomes for Patients With Locally Advanced Cervical Cancer Undergoing Platinum-Based Adjuvant Chemotherapy After Concurrent Chemoradiotherapy.
    Wu N; Su X; Song H; Li Y; Gu F; Sun X; Li X; Cheng G
    Cancer Control; 2021; 28():1073274821989307. PubMed ID: 33593091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
    Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
    J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Therapeutic Value of Adjuvant Chemotherapy after Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer.
    Wang YN; Zhong ML; Liang MR; Yang JT; Zeng SY
    Gynecol Obstet Invest; 2023; 88(5):286-293. PubMed ID: 37497957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial.
    Tangjitgamol S; Tharavichitkul E; Tovanabutra C; Rongsriyam K; Asakij T; Paengchit K; Sukhaboon J; Penpattanagul S; Kridakara A; Hanprasertpong J; Chomprasert K; Wanglikitkoon S; Atjimakul T; Pariyawateekul P; Katanyoo K; Tanprasert P; Janweerachai W; Sangthawan D; Khunnarong J; Chottetanaprasith T; Supawattanabodee B; Lertsanguansinchai P; Srisomboon J; Isaranuwatchai W; Lorvidhaya V
    J Gynecol Oncol; 2019 Jul; 30(4):e82. PubMed ID: 31074236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the efficacy and safety of concurrent chemoradiotherapy by neoadjuvant chemotherapy: a randomized controlled study of locally advanced cervical cancer with a large tumor.
    Li F; Mei F; Yin S; Du Y; Hu L; Hong W; Li J
    J Gynecol Oncol; 2024 Jan; 35(1):e10. PubMed ID: 37857565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes and Sites of Failure in Locally Advanced, Cervical Cancer Patients Treated by Concurrent Chemoradiation with or without Adjuvant Chemotherapy: ACTLACC Trial.
    Tovanabutra C; Asakij T; Rongsriyam K; Tangjitgamol S; Tharavichitkul E; Sukhaboon J; Kridakara LCA; Paengchit K; Khunnarong J; Atjimakul T; Pariyawateekul P; Tanprasert P; Tungkasamit T; Lorvidhaya V
    Asian Pac J Cancer Prev; 2021 Sep; 22(9):2977-2985. PubMed ID: 34582670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between alterations of T-helper 17 cells and treatment efficacy after concurrent radiochemotherapy in locally advanced cervical cancer (stage IIB-IIIB): a 3-year prospective study.
    Liu Y; Guo QF; Chen JL; Li XR; Hou F; Liu XY; Zhang WJ; Zhang Y; Gao FF; Zhang YZ; Cui BX; Liu NF
    Chin Med J (Engl); 2021 Apr; 134(8):954-962. PubMed ID: 33840740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of different chemotherapy regimens concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
    Wu Y; Jiang P; Chen Z; Li W; Dong B; Zhang Y
    BMC Cancer; 2024 May; 24(1):589. PubMed ID: 38745137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trial.
    Weng D; Xiong H; Zhu C; Wan X; Chen Y; Wang X; Zhang Y; Jiang J; Zhang X; Gao Q; Chen G; Xing H; Wang C; Li K; Chen Y; Mao Y; Hu D; Pan Z; Chen Q; Cui B; Song K; Yi C; Peng G; Han X; An R; Fan L; Wang W; Xiong T; Chen Y; Tang Z; Li L; Yang X; Cheng X; Lu W; Wang H; Kong B; Xie X; Ma D
    Front Med; 2023 Feb; 17(1):93-104. PubMed ID: 36422763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
    Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE
    Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of chemotherapy cycles on oncological outcomes in elders with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Tangkananan A; Thongkhao P; Janmunee N; Hanprasertpong J
    J Med Imaging Radiat Oncol; 2022 Oct; 66(7):1014-1021. PubMed ID: 35695633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study.
    Atci MM; Akagunduz B; Demir M; Dönmez Yilmaz B; Akin Telli T; Can O; Cil I; Goktas Aydın S; Ozyurt N; Onder AH; Selvi O; Sakin A
    Oncol Res Treat; 2022; 45(5):254-261. PubMed ID: 35034017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer.
    Li J; Li Y; Wang H; Shen L; Wang Q; Shao S; Shen Y; Xu H; Liu H; Cai R; Feng W
    BMC Cancer; 2023 Jan; 23(1):51. PubMed ID: 36641433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy.
    Takekuma M; Kasamatsu Y; Kado N; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y
    Int J Clin Oncol; 2016 Aug; 21(4):741-747. PubMed ID: 26857458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the survival outcome of neoadjuvant therapy followed by radical surgery with that of concomitant chemoradiotherapy in patients with stage IB2-IIIB cervical adenocarcinoma.
    Tian T; Gao X; Ju Y; Ding X; Ai Y
    Arch Gynecol Obstet; 2021 Mar; 303(3):793-801. PubMed ID: 33009996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of adjuvant chemotherapy for locally advanced cervical cancer: A systematic review and meta-analysis.
    Ma X; Fang J; Zhang L; Huang Y; Shen H; Ma X; Zhang S; Zhang B
    Crit Rev Oncol Hematol; 2023 Apr; 184():103953. PubMed ID: 36889613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent chemoradiotherapy followed by adjuvant chemotherapy versus concurrent chemoradiotherapy alone in locally advanced cervical cancer: A systematic review and meta-analysis.
    Liu H; Ma X; Sun C; Wu M; Xu Z; Zhou S; Yao N; Liu S; Qin X; Han Z
    Front Oncol; 2022; 12():997030. PubMed ID: 36568251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI radiomics in overall survival prediction of local advanced cervical cancer patients tread by adjuvant chemotherapy following concurrent chemoradiotherapy or concurrent chemoradiotherapy alone.
    Wei G; Jiang P; Tang Z; Qu A; Deng X; Guo F; Sun H; Zhang Y; Gu L; Zhang S; Mu W; Wang J; Tian J
    Magn Reson Imaging; 2022 Sep; 91():81-90. PubMed ID: 35636572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.